The emergence of multi-drug resistance in food-borne bacteria is an increasing problem globally. Described by WHO, CDC and other International agencies as one of the world’s most pressing public health threats, antibiotic resistant infections from food-borne bacteria cause an estimated 430,000 illnesses each year in the USA alone. This issue thus has attracted significant attention towards Antimicrobial peptides (AMPs).
The emergence of multi-drug resistance in food-borne bacteria is an increasing problem globally. Described by WHO, CDC and other International agencies as one of the world’s most pressing public health threats, antibiotic resistant infections from food-borne bacteria cause an estimated 430,000 illnesses each year in the USA alone. This issue thus has attracted significant attention towards Antimicrobial peptides (AMPs).
The emergence of multi-drug resistance in food-borne bacteria is an increasing problem globally. Described by WHO, CDC and other International agencies as one of the world’s most pressing public health threats, antibiotic resistant infections from food-borne bacteria cause an estimated 430,000 illnesses each year in the USA alone. This issue thus has attracted significant attention towards Antimicrobial peptides (AMPs).